Trial Profile
A trial to evaluate the relative bioavailability, dose proportionality and safety of deutetrabenazine (SD-809) under fed conditions
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 May 2016
Price :
$35
*
At a glance
- Drugs Deutetrabenazine (Primary)
- Indications Chorea
- Focus Adverse reactions; Pharmacokinetics
- 03 May 2016 New trial record
- 21 Apr 2016 Results presented at the 68th Annual Meeting of the American Academy of Neurology